These AI-Powered ETFs Favor Consumer Stocks for Dividend Growth
(Bloomberg) -- Consumer stocks are the new dividend kings according to two new exchange-traded funds that use artificial intelligence to predict which U.S. and Canadian companies will boost their payouts the fastest.
Bristol Gate Capital Partners Inc., a Toronto-based firm with about C$1.1 billion ($850 million) under management, developed a platform to forecast dividend growth that's evolved in the past decade from a “souped-up Excel model” to a machine-learning algorithm supplemented by fundamental analysis, said President Michael Capombassis.
The algorithm looks at roughly 500 factors to determine what drove dividend growth over the past 20 years and to predict what companies will exhibit those factors in the coming 12 months. Bristol Gate's portfolio managers then apply fundamental analysis to choose the funds' holdings from the model's recommendations.
“The core theme behind our strategy, and this is backed up by our research and by our testing, is that if we could identify the highest dividend-growth stocks in the market in the coming 12 months, and we broadly built a portfolio around those stocks, then over time we would outperform the market with lower downside risk,” Capombassis said in an interview at the firm's offices.
Financials Passe
The resulting Concentrated US Equity ETF and Concentrated Canadian Equity ETF, launched in February, don't look like most other dividend funds. Bristol Gate's U.S. ETF shares only two holdings with the S&P 500 Dividend Aristocrats Total Return Index, arguably the best-known U.S. dividend growth benchmark.
“If you buy the Aristocrats product, it's the assumption that what worked in the past will work in the future, whereas we're looking for companies that are about to go on a sustained run of dividend growth,” said Jamie Houston, manager of sales development at Bristol Gate.
The Canadian ETF only has about 16 percent of its holdings in financials, long favored by dividend-seeking investors, versus 35 percent for the S&P/TSX Composite Index.
“You're not buying the index with either of these two products,” said Capombassis. He cited the example of CVS Health Corp., which was owned by a Bristol Gate fund that was driven by the same strategy as the U.S. ETF. When Bristol Gate bought CVS in 2009, most of the conventional dividend funds ignored it because its yield was too low. But Bristol Gate's algorithm identified it as a dividend grower and, sure enough, its dividend rose by 24 percent annually until it was sold in 2016.
Overweight Industrials
Bristol Gate's U.S. ETF is overweight industrials and consumer discretionary relative to the benchmark. Its holdings include Home Depot Inc., Starbucks Corp., Honeywell International Inc. and Visa Inc. Since the strategy's inception as an offering-memorandum fund in 2009, it has returned 322 percent versus 259 percent for the S&P 500 Total Return Index, according to Bristol Gate.
The Canadian ETF is overweight consumer staples and discretionary, with holdings like Alimentation Couche-Tard Inc., Canadian Tire Corp. and Maple Leaf Foods Inc. The Canadian strategy, which Bristol Gate been running with its own money since 2013, has returned 81 percent versus 53 percent for the S&P/TSX Total Return Index since inception.
To contact the reporter on this story: Kristine Owram in Toronto at kowram@bloomberg.net.
To contact the editors responsible for this story: Jacqueline Thorpe at jthorpe23@bloomberg.net, Arie Shapira at ashapira3@bloomberg.net, Carlos Caminada
©2018 Bloomberg L.P.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.